Xtalks Life Science Podcast
June 19, 2025
In The News
Pharmaceutical Commerce – Pharma Pulse 6/3: Preparing for the Pharma C-Suite
June 3, 2025
CGTLive – The Potential to Apply Immunotherapy DOC1021 to a Broad Array of Tumor Types
June 2, 2025
Texas CEO Magazine – Texas Weekly Deal Highlights 6/1/25
June 1, 2025
CGTLive – Laura Aguilar MD, PhD, on Evaluating Immunotherapy DOC1021 for Glioblastoma
May 31, 2025
In the clinic for April 10, 2025
April 10, 2025
Dr. Laura Aguilar, MD, Ph.D. – Chief Medical Officer – Diakonos Oncology – Immunotherapy For Difficult-To-Treat Indications
March 25, 2025
How non-traditional investors fuel up-and-coming biotechs when VC funding dries up
March 18, 2025
The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach
March 2, 2025
Vaccine Using Dendritic Cells to Treat Aggressive Cancers with Jay Hartenbach Diakonos Oncology
February 17, 2025
Dendritic cell therapy: Diakonos, Northwest Biotherapeutics and Mendus push ahead with next-generation candidates
February 12, 2025
Innovation Map Houston – Houston Oncology Therapeutics Company Raises 11.4M in Seed Funding
August 27, 2024
BioWorld – Diakonos Raises $11.4M for Its Dendritic Cell Vaccine
August 27, 2024
Oncology Nursing News – FDA Grants Fast Track Status to Dendritic Cell Vaccine for Pancreatic Cancer
July 23, 2024
CureToday.com – FDA Fast Tracks Pancreatic Cancer Vaccine
July 19, 2024
Vaccine Nation – Diakonos Announces FDA Fast Track Designation for DCV
July 18, 2024
Targeted Oncology – FDA Fast Tracks Novel Dendritic Cell Vaccine for Pancreatic Cancer
July 16, 2024
MPR – Dendritic Cell Vaccine Fast Tracked for Pancreatic Cancer
July 15, 2024
The Bio Report – Podcast: Boosting the Power of Dendritic Cancer Vaccines
May 15, 2024
Genetic Engineering & Biotechnology News – Dendritic Cell Vaccine Improves Survival Compared to Standard of Care in Phase I Trial for Glioblastoma
April 9, 2024
BioSpace – AACR 2024: What Cancer Researchers Are Talking About
April 5, 2024
Innovation Map Houston – Houston Immuno-oncology Company Reaches Next FDA Milestone, Heads to Phase 2 Trial
February 2, 2024
Houston Chronicle A breakthrough in cancer vaccines may be coming, and Houston is a hub for clinical trials
November 24, 2023
Connect with us on social
